Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 19, 2002 - Issue 1
88
Views
24
CrossRef citations to date
0
Altmetric
Original

Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice

, &
Pages 43-55 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Armiya Sultan, Vivek Choudhary & Arti Parganiha. (2017) Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles. Chronobiology International 34:5, pages 609-623.
Read now
Pasquale F. Innominato, Véronique P. Roche, Oxana G. Palesh, Ayhan Ulusakarya, David Spiegel & Francis A. Lévi. (2014) The circadian timing system in clinical oncology. Annals of Medicine 46:4, pages 191-207.
Read now
Véronique Pasquale Roche, Ali Mohamad-Djafari, Pasquale Fabio Innominato, Abdoulaye Karaboué, Alexander Gorbach & Francis Albert Lévi. (2014) Thoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapy. Chronobiology International 31:3, pages 409-420.
Read now
Constance Ahowesso, Xiao-Mei Li, Sinisa Zampera, Brigitta Peteri-Brunbäck, Sandrine Dulong, Jacques Beau, Virginie Hossard, Elisabeth Filipski, Franck Delaunay, Bruno Claustrat & Francis Lévi. (2011) Sex and Dosing-Time Dependencies in Irinotecan-Induced Circadian Disruption. Chronobiology International 28:5, pages 458-470.
Read now
Bruno Coudert, Christian Focan, Dominique Genet, Sylvie Giacchetti, Frédérique Cvickovic, Alberto Zambelli, Georges Fillet, Philippe Chollet, Domenico Amoroso, Jaak Van Der Auwera, Marie Ange Lentz, Sandrine Marreaud, Benoit Baron, Thierry Gorlia, Fabienne Biville & Francis Lévi. (2008) A Randomized Multicenter Study of Optimal Circadian Time of Vinorelbine Combined with Chronomodulated 5‐Fluorouracil in Pretreated Metastatic Breast Cancer Patients: EORTC Trial 05971. Chronobiology International 25:5, pages 680-696.
Read now
Francis Lévi. (2002) From circadian rhythms to cancer chronotherapeutics. Chronobiology International 19:1, pages 1-19.
Read now

Articles from other publishers (17)

Kyle A. Sullivan, Corena V. Grant, Kelley R. Jordan, Karl Obrietan & Leah M. Pyter. (2022) Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in mice. Brain, Behavior, and Immunity 99, pages 106-118.
Crossref
Kenichiro Kinouchi & Paolo Sassone-Corsi. (2020) Metabolic rivalry: circadian homeostasis and tumorigenesis. Nature Reviews Cancer 20:11, pages 645-661.
Crossref
Zuhair Sadiq, Elizabeth Varghese & Dietrich Büsselberg. (2020) Cisplatin's dual-effect on the circadian clock triggers proliferation and apoptosis. Neurobiology of Sleep and Circadian Rhythms 9, pages 100054.
Crossref
Kyle A. Sullivan, Savannah R. Bever, Daniel B. McKim, Jonathan P. Godbout, John F. Sheridan, Karl Obrietan & Leah M. Pyter. (2019) Mammary tumors compromise time-of-day differences in hypothalamic gene expression and circadian behavior and physiology in mice. Brain, Behavior, and Immunity 80, pages 805-817.
Crossref
Chanel A. Griggs, Scott W. Malm, Rosa Jaime-Frias & Catharine L. Smith. (2018) Valproic acid disrupts the oscillatory expression of core circadian rhythm transcription factors. Toxicology and Applied Pharmacology 339, pages 110-120.
Crossref
Elisabet Ortiz-Tudela, Ida Iurisci, Jacques Beau, Abdoulaye Karaboue, Thierry Moreau, Maria Angeles Rol, Juan Antonio Madrid, Francis Lévi & Pasquale F. Innominato. (2014) The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy. International Journal of Cancer 134:11, pages 2717-2725.
Crossref
E. Ortiz-Tudela, A. Mteyrek, A. Ballesta, P. F. Innominato & F. Lévi. 2013. Circadian Clocks. Circadian Clocks 261 288 .
Pasquale F. Innominato, Sylvie Giacchetti, Georg A. Bjarnason, Christian Focan, Carlo Garufi, Bruno Coudert, Stefano Iacobelli, Marco Tampellini, Xavier Durando, Marie‐Christine Mormont, Jim Waterhouse & Francis A. Lévi. (2012) Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancer. International Journal of Cancer 131:11, pages 2684-2692.
Crossref
Francis Lévi, Alper Okyar, Sandrine Dulong, Pasquale F. Innominato & Jean Clairambault. (2010) Circadian Timing in Cancer Treatments. Annual Review of Pharmacology and Toxicology 50:1, pages 377-421.
Crossref
Francis Lévi, Christian Focan, Abdoulaye Karaboué, Virginie de la Valette, Danielle Focan-Henrard, Benoît Baron, Françoise Kreutz & Sylvie Giacchetti. (2007) Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Advanced Drug Delivery Reviews 59:9-10, pages 1015-1035.
Crossref
X.M. LiF. Lévi. (2016) Circadian Physiology Is a Toxicity Target of the Anticancer Drug Gemcitabine in Mice. Journal of Biological Rhythms 22:2, pages 159-166.
Crossref
Francis LeviUeli Schibler. (2007) Circadian Rhythms: Mechanisms and Therapeutic Implications. Annual Review of Pharmacology and Toxicology 47:1, pages 593-628.
Crossref
Maximilian Moser, Karin Schaumberger, Eva Schernhammer & Richard G. Stevens. (2006) Cancer and Rhythm. Cancer Causes & Control 17:4, pages 483-487.
Crossref
Xiao-Mei Li, Sarath Kanekal, Delphine Crépin, Catherine Guettier, Jennifer Carrière, Gary Elliott & Francis Lévi. (2006) Circadian pharmacology of l -alanosine (SDX-102) in mice . Molecular Cancer Therapeutics 5:2, pages 337-346.
Crossref
Elisabeth Filipski, Franck Delaunay, Verdun M. King, Ming-Wei Wu, Bruno Claustrat, Aline Gréchez-Cassiau, Catherine Guettier, Michael H. Hastings & Lévi Francis. (2004) Effects of Chronic Jet Lag on Tumor Progression in Mice. Cancer Research 64:21, pages 7879-7885.
Crossref
Fabrice Kwiatkowski & Francis Lévi. (2003) Vers le développement des applications médicales de la chronobiologie. Pathologie Biologie 51:4, pages 185-190.
Crossref
B Coudert, C Focan, E Donato di Paola & F Lévi. (2002) It's time for chronotherapy!. European Journal of Cancer 38, pages 50-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.